BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 32453745)

  • 21. Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: A nation-wide, repeated cross-sectional study.
    Soeiro T; Pradel V; Lapeyre-Mestre M; Micallef J
    Addiction; 2023 Oct; 118(10):1984-1993. PubMed ID: 37203878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
    Fink PB; Deyo RA; Hallvik SE; Hildebran C
    Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ecology of prescription opioid abuse in the USA: geographic variation in patients' use of multiple prescribers ("doctor shopping").
    McDonald DC; Carlson KE
    Pharmacoepidemiol Drug Saf; 2014 Dec; 23(12):1258-67. PubMed ID: 25111716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of prescriber risk indicators obtained from prescription drug monitoring program data.
    Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in Opioid Prescribing and Dispensing by Veterinarians in Pennsylvania.
    Clarke DL; Drobatz KJ; Korzekwa C; Nelson LS; Perrone J
    JAMA Netw Open; 2019 Jan; 2(1):e186950. PubMed ID: 30646207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A perioperative approach to the opioid crisis.
    Bai JW; Bao J; Bhatia A; Chan VWS
    CMAJ; 2018 Oct; 190(39):E1151-E1152. PubMed ID: 30274991
    [No Abstract]   [Full Text] [Related]  

  • 29. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group.
    Young LD; Kreiner PW; Panas L
    Pain Med; 2018 Jul; 19(7):1396-1407. PubMed ID: 28383713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Changing Electronic Health Record Opioid Analgesic Dispense Quantity Defaults on the Quantity Prescribed: A Cluster Randomized Clinical Trial.
    Bachhuber MA; Nash D; Southern WN; Heo M; Berger M; Schepis M; Thakral M; Cunningham CO
    JAMA Netw Open; 2021 Apr; 4(4):e217481. PubMed ID: 33885773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
    Guy GP; Zhang K; Bohm MK; Losby J; Lewis B; Young R; Murphy LB; Dowell D
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(26):697-704. PubMed ID: 28683056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
    Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
    Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-prescription network reveals social dynamics of opioid doctor shopping.
    Perry BL; Yang KC; Kaminski P; Odabas M; Park J; Martel M; Oser CB; Freeman PR; Ahn YY; Talbert J
    PLoS One; 2019; 14(10):e0223849. PubMed ID: 31652266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
    Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
    PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012-2017.
    Zhu W; Chernew ME; Sherry TB; Maestas N
    N Engl J Med; 2019 Mar; 380(11):1043-1052. PubMed ID: 30865798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid epidemic in the United States.
    Manchikanti L; Helm S; Fellows B; Janata JW; Pampati V; Grider JS; Boswell MV
    Pain Physician; 2012 Jul; 15(3 Suppl):ES9-38. PubMed ID: 22786464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US.
    Cepeda MS; Fife D; Chow W; Mastrogiovanni G; Henderson SC
    Drug Saf; 2012 Apr; 35(4):325-34. PubMed ID: 22339505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing Electronic Health Record Default Settings to Reduce Opioid Overprescribing: A Pilot Study.
    Zivin K; White JO; Chao S; Christensen AL; Horner L; Petersen DM; Hobbs MR; Capreol G; Halbritter KA; Jones CM
    Pain Med; 2019 Jan; 20(1):103-112. PubMed ID: 29325160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect Of A "No Superuser Opioid Prescription" Policy On ED Visits And Statewide Opioid Prescription.
    Kahler ZP; Musey PI; Schaffer JT; Johnson AN; Strachan CC; Shufflebarger CM
    West J Emerg Med; 2017 Aug; 18(5):894-902. PubMed ID: 28874942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.